Connect with us

Hi, what are you looking for?

Friday, Mar 29, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

Tilray receives approval to distribute cannabis oral solution in Italy

Its FL Group S.R.L. division received approval from the Ministry of Health for its cannabis oral solution THC25

Tilray receives approval to distribute cannabis oral solution in Italy
Photo by LNLNLN via Wikimedia Commons

A Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) division has received approval by the Italian health authorities to start importing and distributing medical cannabis products in the country.

On Thursday, the leading cannabis producer announced that its FL Group S.R.L. division received approval from the Ministry of Health for its cannabis oral solution THC25.

In Italy, medical cannabis authorization is limited but Tilray Medical has established a national pharmaceutical distribution network with FL Group to distribute the oral solution. Patients across Italy may obtain prescriptions for Tilray and other products through their doctor.

Read more: Tilray meets with German authorities to draft adult-use pot regulations

Read more: Tilray receives approval for CBD oral solution in Australia and New Zealand

“Expanding our approved authorization into Italy once again proves our commitment to being the most responsible, trusted and market-leading cannabis company in the world with a portfolio of innovative and high-quality products that address the needs of the patients and consumers we serve,” Tilray’s chief strategy officer Denise Faltischek said.

“We remain dedicated and focused on working with regulators across international markets to advocate for responsible cannabis regulations, best practices, and a reliable source of quality products.”

The company distributes THC and CBD products in 22 countries. Tilray was the first licensed producer of medical cannabis in Canada and sells brands including Tilray, Aphria, Broken Coast, and Symbios.

Tilray stock dropped 5 per cent on Thursday to $3.8 on the Toronto Securities Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Gold

The machine continuously updates and dispenses one-gram bars in real-time to ensure accurate billing for the buyer

Uranium

The new consortium brings the country's one step closer to winning a US$1.87 billion deal to refurbish the plant's unit 1 reactor

Cannabis

The deal is projected to generate craft beer pro forma revenue of $250 million

Cannabis

Tilray's net revenue increased by 20 per cent to $184 million, compared to $153 million in the prior year quarter